A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
LISATA THERAPEUTICS, INC. operates in the Pharmaceutical Preparations industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | 0 | 0 | - | - |
| Net Income | -18M | -20M | -21M | -54M | -16M | 23M |
| EPS | $-2.13 | $-2.40 | $-2.58 | $-157.05 | $-25.05 | $38.40 |
| Free Cash Flow | 0 | -19M | -20M | -21M | -20M | -21M |
| ROIC | -72.9% | -67.6% | -43.3% | -81.4% | -42.9% | 45.5% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.19 | 0.14 | 0.10 | 0.00 | 0.00 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -20M | -22M | -26M | -58M | -17M | -28M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -105.0% | -51.4% | -43.3% | -68.3% | -36.6% | 83.0% |
| Shares Outstanding | 9M | 8M | 8M | 0M | 1M | 1M |
LISATA THERAPEUTICS, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
LISATA THERAPEUTICS, INC. (LSTA) has a 5-year average return on invested capital (ROIC) of -37.9%. This is below average and may indicate limited pricing power.
LISATA THERAPEUTICS, INC. (LSTA) has a market capitalization of $44M. It is classified as a small-cap stock.
LISATA THERAPEUTICS, INC. (LSTA) does not currently pay a regular dividend.
LISATA THERAPEUTICS, INC. (LSTA) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
LISATA THERAPEUTICS, INC. (LSTA) generated $-19 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
LISATA THERAPEUTICS, INC. (LSTA) has a debt-to-equity ratio of 0.19. This indicates a conservatively financed balance sheet.
LISATA THERAPEUTICS, INC. (LSTA) reported earnings per share (EPS) of $-2.40 in its most recent fiscal year.
LISATA THERAPEUTICS, INC. (LSTA) has a return on equity (ROE) of -51.4%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 12 years of financial data for LISATA THERAPEUTICS, INC. (LSTA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
LISATA THERAPEUTICS, INC. (LSTA) has a book value per share of $3.55, based on its most recent annual SEC filing.